| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8733856 | Current Problems in Cancer | 2018 | 9 Pages |
Abstract
Hepatocellular carcinoma is a common malignancy which usually emerges on a background of chronic liver disease. Unfortunately, with contemporary management, patients with advanced hepatocellular carcinoma have few treatment options, and prognosis is poor. The emergence of immunotherapy has afforded new therapeutic opportunities. This article reviews the clinical evidence for immunotherapy in advanced hepatocellular carcinoma and presents ideas for future drug development.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Hao-Wen Sim, Jennifer Knox,